Stockreport

Anavex Life Sciences: Negative CHMP Decision Does Not Bode Well For Future Approval For Alzheimer's [Seeking Alpha]

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
PDF AVXL's Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints, undermining regulatory pathways in both Europe and the U.S. Despite a $1 [Read more]